Antibody nanoparticle conjugate–based targeted immunotherapy for non–small cell lung cancer
Tanmoy Saha(Brigham and Women's Hospital), Shiladitya Sengupta(Harvard University)
Cited by 39
Related Papers
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells
|Nature Nanotechnology|2021|381
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
|Nature Communications|2015|286
Reporter nanoparticle that monitors its anticancer efficacy in real time
|Proceedings of the National Academy of Sciences|2016|76